Loading...

Home
ETF
AVLN

AVLN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AVLN News

Avalyn Pharma Reports $26.9 Million Q1 Net Loss Amid IPO Process

Jun 03 2026seekingalpha

Latest Wall Street Rating Updates

May 26 2026CNBC

Avalyn Pharma and CoStar Group Executives Increase Stock Holdings

May 04 2026NASDAQ.COM

UCB Acquires Candid Therapeutics for Up to $2.2 Billion

May 04 2026Newsfilter

Strong IPO Performance from Biotech Firms

May 01 2026renaissancecapital

April IPO Market Rebounds with $7.3 Billion Raised

May 01 2026renaissancecapital

Avalyn Pharma's IPO Raises $300M, Shares Surge 55%

Apr 30 2026seekingalpha

Avalyn Pharma Raises $300 Million in IPO for Rare Respiratory Treatments

Apr 30 2026renaissancecapital

Avalyn Pharma Increases IPO Size to $283 Million

Apr 30 2026renaissancecapital